Protagenic Therapeutics, Inc.new (PTIX) stock
PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.36MP/E –Yield –
Protagenic Therapeutics, Inc.new free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Protagenic Therapeutics, Inc.new's free cash flow for the twelve months ending Dec 31, 2023 was -$3.85M. For fiscal 2023 it was -$3.85M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$3.85M | – |
| FY2022 | Dec 31, 2022 | -$2.00M | – |
| FY2014 | Jun 30, 2014 | -$791.00K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$1.24M | – |
See a number that looks wrong?